CHRISTINA KIM: Open Payments
NPI 1891227161 · DALLAS, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$921 in 42 payments from 8 companies in 2025. Trend: 2023 $319 · 2024 $497 · 2025 $921
Food & beverage: $864Education: $58
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 20 | $417 |
| Takeda Pharmaceuticals U.S.A., Inc. | 13 | $287 |
| Ardelyx, Inc. | 3 | $83 |
| Janssen Biotech, Inc. | 2 | $37 |
| Lilly USA, LLC | 1 | $26 |
| Regeneron Healthcare Solutions, Inc. | 1 | $26 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $23 |
| Braintree Laboratories, Inc. | 1 | $22 |
Products named: ENTYVIO, BOTOX, RINVOQ, GATTEX, IBSRELA, TREMFYA, CREON, VIBERZI.
Industry payments across TX — which companies pay providers there.
